Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …

The underlying cause of many complications associated with severe COVID-19 is attributed
to the inflammatory cytokine storm that leads to acute respiratory distress syndrome (ARDS) …

Abstract Background The World Health Organization (WHO) announced the COVID-19
occurrence as a global pandemic in March 2020. The treatment of SARS-CoV-2 patients is …

The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Background Coronavirus disease 2019 (COVID-19) has developed into a worldwide
pandemic. This study aimed to retrospectively describe the use of corticosteroids in treating …

Background: We aimed to examine the available evidence regarding the efficacy and safety
of corticosteroids on the management of coronavirus disease 2019 (COVID-19), severe …

Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …

It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …

Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …

Due to a lack of definitive treatment, many drugs were repurposed for Coronavirus disease
(COVID-19) treatment; among them, corticosteroid is one. However, its benefit or harm while …